Vis enkel innførsel

dc.contributor.authorKumar, Mohan
dc.contributor.authorChowdhury, Ranadip
dc.contributor.authorSinha, Bireshwar
dc.contributor.authorUpadhyay, Ravi Prakash
dc.contributor.authorChandola, Temsunaro Rongsen
dc.contributor.authorMazumder, Sarmila
dc.contributor.authorTaneja, Sunita
dc.contributor.authorEdmond, Karen
dc.contributor.authorBahl, Rajiv
dc.contributor.authorBhandari, Nita
dc.contributor.authorRamakrishnan, Usha
dc.contributor.authorRivera, Juan A.
dc.contributor.authorTandon, Sonia
dc.contributor.authorDuggan, Christopher P.
dc.contributor.authorLiu, Enju
dc.contributor.authorFawzi, Wafaie
dc.contributor.authorManji, Karim
dc.contributor.authorChoudhary, Tarun Shankar
dc.date.accessioned2023-04-17T13:03:17Z
dc.date.available2023-04-17T13:03:17Z
dc.date.created2022-10-24T11:56:48Z
dc.date.issued2022
dc.identifier.issn0031-4005
dc.identifier.urihttps://hdl.handle.net/11250/3063380
dc.description.abstractOBJECTIVES To assess effects of supplementation with 3 or more micronutrients (multiple micronutrients; MMN) compared to no MMN in human milk-fed preterm and low birth weight (LBW) infants. RESULTS Data on a subgroup of 414 preterm or LBW infants from 2 randomized controlled trials (4 reports) were included. The certainty of evidence ranged from low to very low. For growth outcomes in the MMN compared to the non-MMN group, there was a small increase in weight-for-age (2 trials, 383 participants) and height-for-age z-scores (2 trials, 372 participants); a small decrease in wasting (2 trials, 398 participants); small increases in stunting (2 trials, 399 participants); and an increase in underweight (2 trials, 396 participants). For neurodevelopment outcomes at 78 weeks, we found small increases in Bayley Scales of Infant Development, Version III (BISD-III), scores (cognition, receptive language, expressive language, fine motor, gross motor) in the MMN compared to the non-MMN group (1 trial, 27 participants). There were no studies examining dose or timing of supplementation. CONCLUSIONS Evidence is insufficient to determine whether enteral MMN supplementation to preterm or LBW infants who are fed mother's own milk is associated with benefit or harm. More trials are needed to generate evidence on mortality, morbidity, growth, and neurodevelopment.en_US
dc.language.isoengen_US
dc.publisherAAPen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleEnteral Multiple Micronutrient Supplementation in Preterm and Low Birth Weight Infants: A Systematic Review and Meta-analysisen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.source.articlenumbere2022057092Nen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1542/peds.2022-057092N
dc.identifier.cristin2064319
dc.source.journalPediatricsen_US
dc.relation.projectNorges forskningsråd: 223269en_US
dc.identifier.citationPediatrics. 2022, 150 (Supplement 1), e2022057092N.en_US
dc.source.volume150en_US
dc.source.issueSupplement 1en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal